US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 180 actively recruiting studies with Wisconsin sites out of 180 registered in total. The busiest research areas in Wisconsin are Endometrial Cancer, Breast Cancer, Lung Cancer. Leading sponsors running trials in the state include University of Wisconsin, Madison, Medical College of Wisconsin, National Cancer Institute (NCI). By stage, Wisconsin trials break down as Phase 1 (28), Phase 2 (41), Phase 3 (46), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
180
Recruiting Now
180
← Back to US Map
Top Conditions in Wisconsin
Endometrial Cancer (5)Breast Cancer (4)Lung Cancer (4)Bladder Cancer (4)Healthy Participants (3)Advanced Solid Tumor (3)Obesity (3)Prostate Adenocarcinoma (3)Metastatic Renal Cell Carcinoma (3)Stage IV Renal Cell Cancer AJCC v8 (3)Prostate Cancer (3)Cancer (3)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 180 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 180. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Endometrial Cancer, Breast Cancer, Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT06580314 Phase 3
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ova...
Condition
Fallopian Tube Endometrioid Adenocarcinoma
Enrollment
880 pts
Location
United States, Japan, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT04174352 EARLY_Phase 1
Recruiting
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
Condition
ERα+ Breast Cancer
Enrollment
12 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06764485 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
960 pts
Location
United States, Argentina, Australia
Sponsor
Celgene
View Trial →
NCT06990399 Phase 3
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in P...
Condition
Macular Edema Secondary to Inflammation
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
Kodiak Sciences Inc
View Trial →
NCT04153292 N/A
Recruiting
The ENCIRCLE Trial
Condition
Mitral Regurgitation
Enrollment
900 pts
Location
United States, Australia, Canada
Sponsor
Edwards Lifesciences
View Trial →
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06679634 Phase 2
Recruiting
Retinoblastoma Phase II Expanded Access Clinical Trial
Condition
Retinoblastoma
Enrollment
30 pts
Location
United States
Sponsor
Targeted Therapy Technologies,
View Trial →
NCT07044336 Phase 3
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected End...
Condition
Endometrial Cancer
Enrollment
800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05653232 N/A
Recruiting
Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-In...
Condition
HCV
Enrollment
120 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT05521698 Phase 1
Recruiting
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
80 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06730347 Phase 2
Recruiting
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Condition
Platinum-resistant Ovarian Cancer
Enrollment
80 pts
Location
United States, Canada, South Korea
Sponsor
MacroGenics
View Trial →
NCT06256458 N/A
Recruiting
Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Traum...
Condition
Fractures, Bone
Enrollment
200 pts
Location
United States
Sponsor
Artoss Inc.
View Trial →
NCT05854498 Phase 2
Recruiting
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Co...
Condition
Metastatic Colorectal Cancer
Enrollment
50 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT07369752 N/A
Recruiting
Enhancing Brain And Mental Health Through Breathing Practice
Condition
Depressive Disorder
Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06906562 Phase 2
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in...
Condition
Advanced Pancreatic Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
Sameek Roychowdhury
View Trial →
NCT07224373 Phase 1
Recruiting
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
24 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT06353386 Phase 1, Phase 2
Recruiting
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combi...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
220 pts
Location
United States, Australia, Canada
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07479979 Phase 1, Phase 2
Recruiting
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients W...
Condition
Relapse Multiple Myeloma
Enrollment
62 pts
Location
United States
Sponsor
Natalie Callander
View Trial →
NCT05630989 N/A
Recruiting
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreati...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
80 pts
Location
United States
Sponsor
Mandana Kamgar, MD
View Trial →
NCT06705686 Phase 1
Recruiting
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Condition
Metastatic Castration-resistant Prostate Cancer (CRPC)
Enrollment
40 pts
Location
United States
Sponsor
TechnoGenesys, Inc.
View Trial →
NCT06568536 N/A
Recruiting
Measuring Brain Complexity to Detect and Predict Recovery of Consciousness in th...
Condition
Consciousness Disorders
Enrollment
120 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT04205968 Phase 2
Recruiting
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Condition
Metastatic Small Intestinal Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT06679270 Phase 3
Recruiting
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipo...
Condition
Familial Partial Lipodystrophy
Enrollment
24 pts
Location
United States
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →
Page 6 of 8 — 180 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology